New reports show Philly’s cell and gene therapy industry is ‘rapidly growing.’ Can it become the top hub for research and innovation?

The announcement comes after environmentalists took legal action to speed up the process.

Researchers at Temple University will look at the effectiveness of the Chance to Ride travel training program and recruit participants in Philly.

For Katherine High, president and chief scientific officer at Spark Therapeutics, the drug’s approval signals renewed hope in the possibilities of gene therapy.